TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region
With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one owner Advancing felzartamab – a CD38-directed antibody with potential broad applicability...
ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation
SHANGHAI, April 7, 2026 /PRNewswire/ -- ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreement with Daiichi Sankyo to leverage ATLATL's...
NPCI International signs agreement with Payments Network Malaysia to enable UPI and DuitNow acceptance in India and Malaysia
MUMBAI, India, Feb. 13, 2026 /PRNewswire/ -- NPCI International Payments Limited (NIPL), the international arm of the National Payments Corporation of India (NPCI), has signed an agreement with Payments Network Malaysia Sdn Bhd (PayNet) — Malaysia's...
Theori and Okta Enter Agreement to Enhance Security Posture and Resilience
SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Theori, a leading offensive security firm specializing in advanced threat simulation, today announced a new agreement with Okta, the leading independent Identity partner. This engagement will leverage...
SS&C Signs Agreement with Insignia Financial
WINDSOR, Conn., Dec. 10, 2024 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced an initial agreement with Insignia Financial (Insignia) to deliver superannuation member administration services. Insignia Financial...